Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BP 1.4979 in Restless Legs Syndrome
NCT03345953Phase 2Terminated
- Sponsor
- Bioprojet
- Start
- Feb 2018
- Primary completion
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of BP-1.4979 in restless legs syndrome (RLS), sponsored by Bioprojet. Started Feb 2018; status: terminated.
02
Drugs
BP-1.4979
03
Conditions
restless legs syndrome (RLS)
Beyond the preview
Go deeper on NCT03345953.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03345953.